Conclusion Permanently changing eye colour in healthy eyes for purely cosmetic reasons is a risky procedure
TREATMENT NL is a chronic, disfiguring condition that can be debilitating for patients and difficult for clinicians to manage
Documented buccal protocols: Buccal strips offer a practical middle ground: bioavailability meaningfully higher than oral capsules, without requiring injection
Injectable healing protocol: 23 mg daily (upper end of range), systemic injection - not into the wound itself - daily until the wound resolves, plus 12 weeks maintenance Topical healing protocol: 2 %4 % in a wound-appropriate vehicle applied 23 times daily to wound margins (never into an open, actively bleeding wound) under clinician supervision Stacking: GHK-Cu pairs exceptionally well with BPC-157 and TB-500 - the so-called GLOW stack - for complex healing cases
Koehler JA, Baggio LL, Cao X et al (2015) Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis
Common structural basis for constitutive activity of the ghrelin receptor family